204 related articles for article (PubMed ID: 18398546)
21. Magnetic resonance imaging of contrast-enhanced polyelectrolyte complexes.
Huang M; Huang ZL; Bilgen M; Berkland C
Nanomedicine; 2008 Mar; 4(1):30-40. PubMed ID: 18201943
[TBL] [Abstract][Full Text] [Related]
22. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
[TBL] [Abstract][Full Text] [Related]
23. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
Mishra A; Pfeuffer J; Mishra R; Engelmann J; Mishra AK; Ugurbil K; Logothetis NK
Bioconjug Chem; 2006; 17(3):773-80. PubMed ID: 16704217
[TBL] [Abstract][Full Text] [Related]
24. Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64).
Kobayashi H; Saga T; Kawamoto S; Sato N; Hiraga A; Ishimori T; Konishi J; Togashi K; Brechbiel MW
Cancer Res; 2001 Jul; 61(13):4966-70. PubMed ID: 11431325
[TBL] [Abstract][Full Text] [Related]
25. Gold nanoparticles functionalised by Gd-complex of DTPA-bis(amide) conjugate of glutathione as an MRI contrast agent.
Park JA; Reddy PA; Kim HK; Kim IS; Kim GC; Chang Y; Kim TJ
Bioorg Med Chem Lett; 2008 Dec; 18(23):6135-7. PubMed ID: 18938074
[TBL] [Abstract][Full Text] [Related]
26. Toward optimized high-relaxivity MRI agents: thermodynamic selectivity of hydroxypyridonate/catecholate ligands.
Pierre VC; Melchior M; Doble DM; Raymond KN
Inorg Chem; 2004 Dec; 43(26):8520-5. PubMed ID: 15606201
[TBL] [Abstract][Full Text] [Related]
27. The effect of ligand scaffold size on the stability of tripodal hydroxypyridonate gadolinium complexes.
O'Sullivan B; Doble DM; Thompson MK; Siering C; Xu J; Botta M; Aime S; Raymond KN
Inorg Chem; 2003 Apr; 42(8):2577-83. PubMed ID: 12691564
[TBL] [Abstract][Full Text] [Related]
28. Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors.
Mi P; Kokuryo D; Cabral H; Kumagai M; Nomoto T; Aoki I; Terada Y; Kishimura A; Nishiyama N; Kataoka K
J Control Release; 2014 Jan; 174():63-71. PubMed ID: 24211705
[TBL] [Abstract][Full Text] [Related]
29. Probing the interaction of the biotin-avidin complex with the relaxivity of biotinylated Gd-DTPA.
Langereis S; Kooistra HA; van Genderen MH; Meijer EW
Org Biomol Chem; 2004 May; 2(9):1271-3. PubMed ID: 15105914
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, complexation and water exchange properties of Gd(III)-TTDA-mono and bis(amide) derivatives and their binding affinity to human serum albumin.
Ou MH; Chen YM; Chang YH; Lu WK; Liu GC; Wang YM
Dalton Trans; 2007 Jul; (26):2749-59. PubMed ID: 17592591
[TBL] [Abstract][Full Text] [Related]
31. Development of a conjugated gadolinium and cisplatin-gelatin possessing properties as an intravascular contrast agent for MR imaging.
Sonoda A; Nitta N; Ohta S; Seko A; Jo J; Morikawa S; Tabata Y; Takahashi M; Murata K
Eur J Radiol; 2009 Sep; 71(3):570-5. PubMed ID: 18502598
[TBL] [Abstract][Full Text] [Related]
32. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
[TBL] [Abstract][Full Text] [Related]
33. PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging.
Mohs AM; Wang X; Goodrich KC; Zong Y; Parker DL; Lu ZR
Bioconjug Chem; 2004; 15(6):1424-30. PubMed ID: 15546211
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents.
Yan GP; Hu B; Liu ML; Li LY
J Pharm Pharmacol; 2005 Mar; 57(3):351-7. PubMed ID: 15807991
[TBL] [Abstract][Full Text] [Related]
35. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.
Peller M; Schwerdt A; Hossann M; Reinl HM; Wang T; Sourbron S; Ogris M; Lindner LH
Invest Radiol; 2008 Dec; 43(12):877-92. PubMed ID: 19002060
[TBL] [Abstract][Full Text] [Related]
36. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
[TBL] [Abstract][Full Text] [Related]
37. Toward optimized high-relaxivity MRI agents: the effect of ligand basicity on the thermodynamic stability of hexadentate hydroxypyridonate/catecholate gadolinium(III) complexes.
Doble DM; Melchior M; O'Sullivan B; Siering C; Xu J; Pierre VC; Raymond KN
Inorg Chem; 2003 Aug; 42(16):4930-7. PubMed ID: 12895117
[TBL] [Abstract][Full Text] [Related]
38. Gold nanoparticles functionalized by gadolinium-DTPA conjugate of cysteine as a multimodal bioimaging agent.
Park JA; Kim HK; Kim JH; Jeong SW; Jung JC; Lee GH; Lee J; Chang Y; Kim TJ
Bioorg Med Chem Lett; 2010 Apr; 20(7):2287-91. PubMed ID: 20188545
[TBL] [Abstract][Full Text] [Related]
39. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
40. Polyamine-substituted gadolinium chelates: a new class of intracellular contrast agents for magnetic resonance imaging of tumors.
Wolf M; Hull WE; Mier W; Heiland S; Bauder-Wüst U; Kinscherf R; Haberkorn U; Eisenhut M
J Med Chem; 2007 Jan; 50(1):139-48. PubMed ID: 17201417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
